APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Saphris (Asenapine)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Saphris (Asenapine) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174033940322 December 2025175 pages

Choose your research edition.

Industry ResearchSaphris (Asenapine) Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Saphris (Asenapine) Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Saphris (Asenapine) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Saphris (Asenapine) Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Saphris (Asenapine) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Saphris (Asenapine) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Saphris (Asenapine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Saphris (Asenapine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Saphris (Asenapine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Saphris (Asenapine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Saphris (Asenapine) include Merck & Co., Inc., Allergan plc (AbbVie Inc.) and Actavis Generics (Teva), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Saphris (Asenapine) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Saphris (Asenapine) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Saphris (Asenapine) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Saphris (Asenapine) market size, projected growth trends, production technologies, key applications, and end-use industries.

Saphris (Asenapine) Segment by Company

Merck & Co., Inc.

Allergan plc (AbbVie Inc.)

Actavis Generics (Teva)

Saphris (Asenapine) Segment by Type

5 mg

10 mg

Saphris (Asenapine) Segment by Application

Schizophrenia

Acute Mania

Others

Saphris (Asenapine) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Saphris (Asenapine) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Saphris (Asenapine) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Saphris (Asenapine).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Saphris (Asenapine) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Saphris (Asenapine) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Saphris (Asenapine) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Saphris (Asenapine) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Saphris (Asenapine) Industry Trends Table 2. Saphris (Asenapine) Industry Drivers Table 3. Saphris (Asenapine) Industry Opportunities and Challenges Table 4. Saphris (Asenapine) Industry Restraints Table 5. Global Saphris (Asenapine) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Saphris (Asenapine) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Saphris (Asenapine) Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Saphris (Asenapine) Sales Market Share by Manufacturers Table 9. Global Saphris (Asenapine) Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Saphris (Asenapine) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Saphris (Asenapine) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Saphris (Asenapine) Manufacturers, Product Type & Application Table 13. Global Saphris (Asenapine) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Saphris (Asenapine) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 5 mg Table 17. Major Manufacturers of 10 mg Table 18. Global Saphris (Asenapine) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Saphris (Asenapine) Sales by Type (2021-2026) & (k units) Table 20. Global Saphris (Asenapine) Sales by Type (2027-2032) & (k units) Table 21. Global Saphris (Asenapine) Sales Market Share by Type (2021-2026) Table 22. Global Saphris (Asenapine) Sales Market Share by Type (2027-2032) Table 23. Global Saphris (Asenapine) Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Saphris (Asenapine) Revenue by Type (2021-2026) & (k units) Table 25. Global Saphris (Asenapine) Revenue by Type (2027-2032) & (k units) Table 26. Global Saphris (Asenapine) Revenue Market Share by Type (2021-2026) Table 27. Global Saphris (Asenapine) Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Schizophrenia Table 29. Major Manufacturers of Acute Mania Table 30. Major Manufacturers of Others Table 31. Global Saphris (Asenapine) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Saphris (Asenapine) Sales by Application (2021-2026) & (k units) Table 33. Global Saphris (Asenapine) Sales by Application (2027-2032) & (k units) Table 34. Global Saphris (Asenapine) Sales Market Share by Application (2021-2026) Table 35. Global Saphris (Asenapine) Sales Market Share by Application (2027-2032) Table 36. Global Saphris (Asenapine) Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Saphris (Asenapine) Revenue by Application (2021-2026) & (k units) Table 38. Global Saphris (Asenapine) Revenue by Application (2027-2032) & (k units) Table 39. Global Saphris (Asenapine) Revenue Market Share by Application (2021-2026) Table 40. Global Saphris (Asenapine) Revenue Market Share by Application (2027-2032) Table 41. Global Saphris (Asenapine) Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Saphris (Asenapine) Sales by Region (2021-2026) & (k units) Table 43. Global Saphris (Asenapine) Sales Market Share by Region (2021-2026) Table 44. Global Saphris (Asenapine) Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Saphris (Asenapine) Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Saphris (Asenapine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Saphris (Asenapine) Sales by Country (2021-2026) & (k units) Table 48. North America Saphris (Asenapine) Sales by Country (2027-2032) & (k units) Table 49. Europe Saphris (Asenapine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Saphris (Asenapine) Sales by Country (2021-2026) & (k units) Table 51. Europe Saphris (Asenapine) Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Saphris (Asenapine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Saphris (Asenapine) Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Saphris (Asenapine) Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Saphris (Asenapine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Saphris (Asenapine) Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Saphris (Asenapine) Sales by Country (2027-2032) & (k units) Table 58. Global Saphris (Asenapine) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Saphris (Asenapine) Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Saphris (Asenapine) Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Saphris (Asenapine) Revenue Market Share by Region (2021-2026) Table 62. Global Saphris (Asenapine) Revenue Market Share by Region (2027-2032) Table 63. Merck & Co., Inc. Company Information Table 64. Merck & Co., Inc. Business Overview Table 65. Merck & Co., Inc. Saphris (Asenapine) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Merck & Co., Inc. Saphris (Asenapine) Product Portfolio Table 67. Merck & Co., Inc. Recent Development Table 68. Allergan plc (AbbVie Inc.) Company Information Table 69. Allergan plc (AbbVie Inc.) Business Overview Table 70. Allergan plc (AbbVie Inc.) Saphris (Asenapine) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Allergan plc (AbbVie Inc.) Saphris (Asenapine) Product Portfolio Table 72. Allergan plc (AbbVie Inc.) Recent Development Table 73. Actavis Generics (Teva) Company Information Table 74. Actavis Generics (Teva) Business Overview Table 75. Actavis Generics (Teva) Saphris (Asenapine) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Actavis Generics (Teva) Saphris (Asenapine) Product Portfolio Table 77. Actavis Generics (Teva) Recent Development Table 78. Key Raw Materials Table 79. Raw Materials Key Suppliers Table 80. Saphris (Asenapine) Distributors List Table 81. Saphris (Asenapine) Customers List Table 82. Research Programs/Design for This Report Table 83. Authors List of This Report Table 84. Secondary Sources Table 85. Primary Sources List of Figures Figure 1. Saphris (Asenapine) Product Image Figure 2. Global Saphris (Asenapine) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Saphris (Asenapine) Market Size (2021-2032) & (US$ Million) Figure 4. Global Saphris (Asenapine) Sales (2021-2032) & (k units) Figure 5. Global Saphris (Asenapine) Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Saphris (Asenapine) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 5 mg Image Figure 9. 10 mg Image Figure 10. Global Saphris (Asenapine) Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Saphris (Asenapine) Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Saphris (Asenapine) Sales Market Share by Type (2021-2032) Figure 13. Global Saphris (Asenapine) Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Saphris (Asenapine) Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Saphris (Asenapine) Revenue Market Share by Type (2021-2032) Figure 16. Schizophrenia Image Figure 17. Acute Mania Image Figure 18. Others Image Figure 19. Global Saphris (Asenapine) Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Saphris (Asenapine) Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Saphris (Asenapine) Sales Market Share by Application (2021-2032) Figure 22. Global Saphris (Asenapine) Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Saphris (Asenapine) Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Saphris (Asenapine) Revenue Market Share by Application (2021-2032) Figure 25. North America Saphris (Asenapine) Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Saphris (Asenapine) Sales Market Share by Country (2021-2032) Figure 27. U.S. Saphris (Asenapine) Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Saphris (Asenapine) Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Saphris (Asenapine) Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Saphris (Asenapine) Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Saphris (Asenapine) Sales Market Share by Country (2021-2032) Figure 32. Germany Saphris (Asenapine) Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Saphris (Asenapine) Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Saphris (Asenapine) Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Saphris (Asenapine) Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Saphris (Asenapine) Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Saphris (Asenapine) Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Saphris (Asenapine) Sales Market Share by Country (2021-2032) Figure 39. China Saphris (Asenapine) Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Saphris (Asenapine) Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Saphris (Asenapine) Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Saphris (Asenapine) Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Saphris (Asenapine) Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Saphris (Asenapine) Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Saphris (Asenapine) Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Saphris (Asenapine) Sales Market Share by Country (2021-2032) Figure 47. Brazil Saphris (Asenapine) Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Saphris (Asenapine) Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Saphris (Asenapine) Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Saphris (Asenapine) Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Saphris (Asenapine) Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Saphris (Asenapine) Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Saphris (Asenapine) Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Saphris (Asenapine) Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Saphris (Asenapine) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Saphris (Asenapine) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Figure 58. North America Saphris (Asenapine) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Figure 60. Europe Saphris (Asenapine) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Saphris (Asenapine) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Saphris (Asenapine) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Saphris (Asenapine) Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Saphris (Asenapine) Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 5 mg
  • 10 mg
Applications
  • Schizophrenia
  • Acute Mania
  • Others
Companies covered
  • Merck & Co., Inc.
  • Allergan plc (AbbVie Inc.)
  • Actavis Generics (Teva)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Saphris (Asenapine) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Saphris (Asenapine) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Saphris (Asenapine) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Saphris (Asenapine) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Saphris (Asenapine) Market Dynamics
  1. 2.1 Saphris (Asenapine) Industry Trends
  2. 2.2 Saphris (Asenapine) Industry Drivers
  3. 2.3 Saphris (Asenapine) Industry Opportunities and Challenges
  4. 2.4 Saphris (Asenapine) Industry Restraints
3 Saphris (Asenapine) Market by Manufacturers
  1. 3.1 Global Saphris (Asenapine) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Saphris (Asenapine) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Saphris (Asenapine) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Saphris (Asenapine) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Saphris (Asenapine) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Saphris (Asenapine) Manufacturers, Product Type & Application
  7. 3.7 Global Saphris (Asenapine) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Saphris (Asenapine) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Saphris (Asenapine) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Saphris (Asenapine) Tier 1, Tier 2, and Tier 3
4 Saphris (Asenapine) Market by Type
  1. 4.1 Saphris (Asenapine) Type Introduction
  2. 4.1.1 5 mg
  3. 4.1.2 10 mg
  4. 4.2 Global Saphris (Asenapine) Sales by Type
  5. 4.2.1 Global Saphris (Asenapine) Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Saphris (Asenapine) Sales by Type (2021-2032)
  7. 4.2.3 Global Saphris (Asenapine) Sales Market Share by Type (2021-2032)
  8. 4.3 Global Saphris (Asenapine) Revenue by Type
  9. 4.3.1 Global Saphris (Asenapine) Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Saphris (Asenapine) Revenue by Type (2021-2032)
  11. 4.3.3 Global Saphris (Asenapine) Revenue Market Share by Type (2021-2032)
5 Saphris (Asenapine) Market by Application
  1. 5.1 Saphris (Asenapine) Application Introduction
  2. 5.1.1 Schizophrenia
  3. 5.1.2 Acute Mania
  4. 5.1.3 Others
  5. 5.2 Global Saphris (Asenapine) Sales by Application
  6. 5.2.1 Global Saphris (Asenapine) Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Saphris (Asenapine) Sales by Application (2021-2032)
  8. 5.2.3 Global Saphris (Asenapine) Sales Market Share by Application (2021-2032)
  9. 5.3 Global Saphris (Asenapine) Revenue by Application
  10. 5.3.1 Global Saphris (Asenapine) Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Saphris (Asenapine) Revenue by Application (2021-2032)
  12. 5.3.3 Global Saphris (Asenapine) Revenue Market Share by Application (2021-2032)
6 Global Saphris (Asenapine) Sales by Region
  1. 6.1 Global Saphris (Asenapine) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Saphris (Asenapine) Sales by Region (2021-2032)
  3. 6.2.1 Global Saphris (Asenapine) Sales by Region (2021-2026)
  4. 6.2.2 Global Saphris (Asenapine) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Saphris (Asenapine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Saphris (Asenapine) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Saphris (Asenapine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Saphris (Asenapine) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Saphris (Asenapine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Saphris (Asenapine) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Saphris (Asenapine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Saphris (Asenapine) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Saphris (Asenapine) Revenue by Region
  1. 7.1 Global Saphris (Asenapine) Revenue by Region
  2. 7.1.1 Global Saphris (Asenapine) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Saphris (Asenapine) Revenue by Region (2021-2026)
  4. 7.1.3 Global Saphris (Asenapine) Revenue by Region (2027-2032)
  5. 7.1.4 Global Saphris (Asenapine) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Saphris (Asenapine) Revenue (2021-2032)
  8. 7.2.2 North America Saphris (Asenapine) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Saphris (Asenapine) Revenue (2021-2032)
  11. 7.3.2 Europe Saphris (Asenapine) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Saphris (Asenapine) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Saphris (Asenapine) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Saphris (Asenapine) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Saphris (Asenapine) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck & Co., Inc.
  2. 8.1.1 Merck & Co., Inc. Company Information
  3. 8.1.2 Merck & Co., Inc. Business Overview
  4. 8.1.3 Merck & Co., Inc. Saphris (Asenapine) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck & Co., Inc. Saphris (Asenapine) Product Portfolio
  6. 8.1.5 Merck & Co., Inc. Recent Developments
  7. 8.2 Allergan plc (AbbVie Inc.)
  8. 8.2.1 Allergan plc (AbbVie Inc.) Company Information
  9. 8.2.2 Allergan plc (AbbVie Inc.) Business Overview
  10. 8.2.3 Allergan plc (AbbVie Inc.) Saphris (Asenapine) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Allergan plc (AbbVie Inc.) Saphris (Asenapine) Product Portfolio
  12. 8.2.5 Allergan plc (AbbVie Inc.) Recent Developments
  13. 8.3 Actavis Generics (Teva)
  14. 8.3.1 Actavis Generics (Teva) Company Information
  15. 8.3.2 Actavis Generics (Teva) Business Overview
  16. 8.3.3 Actavis Generics (Teva) Saphris (Asenapine) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Actavis Generics (Teva) Saphris (Asenapine) Product Portfolio
  18. 8.3.5 Actavis Generics (Teva) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Saphris (Asenapine) Value Chain Analysis
  2. 9.1.1 Saphris (Asenapine) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Saphris (Asenapine) Production Mode & Process
  6. 9.2 Saphris (Asenapine) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Saphris (Asenapine) Distributors
  9. 9.2.3 Saphris (Asenapine) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst